Status:
UNKNOWN
Assessment of Nerve Damage Biomarkers in Acute and Chronic Organophosphate Toxicity
Lead Sponsor:
Alexandria University
Conditions:
Neuroinflammatory Response
Nerve Injury
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this observational study is to answer the following questions in individuals with acute and chronic exposure to organophosphates. The main questions to be addressed are 1. What are the pro...
Detailed Description
This is a cross-sectional study that aims to assess the possible prognostic value of markers of neuroinflammation and nerve damage in patients with acute and chronic exposure to organophosphate pestic...
Eligibility Criteria
Inclusion
- For the control group: healthy individuals without previous exposure to organophosphates, with the specified age limits.
- For the acute exposure group: patients with acute exposure to organophosphates, with the specified age limits
- For the chronic exposure group: patients with chronic exposure to organophosphates, with the specified age limits
- No restrictions on comorbidities in the three groups except those mentioned under Exclusion Criteria
Exclusion
- Pediatric patients.
- Patients with neurological diseases (Parkinsonism, epilepsy, Alzheimer's disease, etc.)
- Patients who does not meet the inclusion criteria.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06021262
Start Date
August 1 2023
End Date
January 1 2024
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria Main University Hospital
Alexandria, Egypt